Effects of anakinra on the LV end-systolic volume index in patients with myocardial infarction

Trial Profile

Effects of anakinra on the LV end-systolic volume index in patients with myocardial infarction

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Anakinra (Primary)
  • Indications Heart failure; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms VCU-ART2
  • Most Recent Events

    • 06 Jul 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01175018).
    • 19 Mar 2013 New trial record
    • 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top